Enanta Pharmaceuticals Aktie
6,20
EUR
-0,10
EUR
-1,59
%
7,41
USD
+0,08
USD
+1,02
%
Werbung
Enanta Pharmaceuticals Aktie Analyse
24.05.19 | Enanta Pharmaceuticals Outperform | Wolfe Research | |
02.01.18 | Enanta Pharmaceuticals Sector Perform | RBC Capital Markets | |
21.11.17 | Enanta Pharmaceuticals Outperform | RBC Capital Markets | |
15.09.17 | Enanta Pharmaceuticals Outperform | RBC Capital Markets | |
07.08.15 | Enanta Pharmaceuticals Equal weight | Barclays Capital | |
06.04.15 | Enanta Pharmaceuticals Buy | Deutsche Bank AG | |
04.03.15 | Enanta Pharmaceuticals Equal weight | Barclays Capital |
Werbung
Werbung